altimmune glp-1 Effect of pemvidutide, a GLP-1/glucagon dual receptor agonist, on MASLD: A randomized, double-blind, placebo-controlled study Altimmune's GLP-1 Drug Reduces Heavy

According to Diabetes Daily, a recent survey by Thrivable, a diabetes market research firm, demonstrated that people with type 1 diabetes who use GLP-1 drugs are far more likely to think positively about the future of diabetes treatment: 41.2 percent of GLP-1 users reported feeling optimistic, compared with a mere 5.6 percent of nonusers

Some studies have found that sufficient vitamin B12 levels can help lower the risk of weight gain

, Mediator effects of parameters of inflammation and neurogenesis from a N-acetyl cysteine clinical-trial for bipolar depression, Acta Neuropsychiatr

Stress may influence both eating behaviours and gastrointestinal symptoms, making these approaches particularly valuable